(Q30080035)
Statements
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial (English)
Schmutzler RK
Weitzel JN
Tutt A
Garber JE
Domchek SM
Audeh MW
Friedlander M
Arun B
Loman N
Wardley A
Mitchell G
Earl H
Wickens M
Carmichael J
24 July 2010
235-44
9737